Old Saybrook, CT, United States of America

Louis Stanley Chupak

This inventor holds 23 USPTO granted patents and 4 published patent applications and 10 EPO patents, primarily in Immunomodulator Compounds. Top assignees: Bristol-Myers Squibb Compnay, Pfizer Corporation, Pfizer Products Inc.. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis Stanley Chupak. Retrieved from https://idiyas.com/inventor/louis-stanley-chupak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 4)

% Patents Active = 78.3

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 191(Granted Patents)

Company Filing History:

13 out of 3,742

Bristol-Myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

T Cell Activators

Immunomodulators

Hepatitis C Treatment

Aryl Compounds

Glycine Chroman

Diacylglycerol Lipase

Aggrecanase Inhibition

Metalloproteinase Inhibitors

VLA-4 Inhibitors

Non-Peptidyl Inhibitors

Osteoarthritis Treatment

Autoimmune Diseases

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11964973 - Substituted bicyclic compounds useful as T cell activators (2024-04-23),

2. 11866430 - Naphthyridinone compounds useful as T cell activators (2024-01-09),

3. 11713316 - Substituted naphthyridinone compounds useful as T cell activators (2023-08-01),

4. 10954238 - Substituted naphthyridinone compounds useful as T cell activators (2021-03-23),

5. 10669272 - Substituted naphthyridinone compounds useful as T cell activators (2020-06-02),

6. 10517870 - Aryl substituted bicycle heteroaryl compounds (2019-12-31),

7. 9872852 - Compounds useful as immunomodulators (2018-01-23),

8. 9850225 - Compounds useful as immunomodulators (2017-12-26),

9. 8536338 - Compounds for the treatment of hepatitis C (2013-09-17),

10. 8404741 - Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase (2013-03-26),

11. 8354548 - Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase (2013-01-15),

12. 8293909 - Compounds for the treatment of hepatitis C (2012-10-23),

13. 8198449 - Compounds for the treatment of hepatitis C (2012-06-12),

14. 7462600 - Macrolides (2008-12-09),

15. 7030242 - Selective inhibition of aggrecanase in osteoarthritis treatment (2006-04-18),

Title: The Innovative Journey of Louis Stanley Chupak

Introduction: Louis Stanley Chupak, a distinguished inventor hailing from Old Saybrook, CT (US), has made significant contributions to the world of innovations with his creative mind and relentless pursuit of excellence.

Latest Patents: Louis Stanley Chupak holds several patents in various fields, showcasing his versatility and ingenuity in inventing cutting-edge solutions to complex problems.

Career Highlights: Throughout his illustrious career, Louis Stanley Chupak has been at the forefront of technological advancements, revolutionizing industries with his groundbreaking inventions. His passion for innovation has led to the development of game-changing products that have left a lasting impact.

Collaborations: Louis Stanley Chupak has collaborated with leading experts and organizations in the field of technology, pooling together knowledge and expertise to push the boundaries of what is possible. His collaborative spirit has been instrumental in bringing revolutionary ideas to life.

Conclusion: In conclusion, Louis Stanley Chupak stands as a beacon of innovation, inspiring generations of inventors to think outside the box and pursue their creative visions. His remarkable contributions to the world of inventions have cemented his legacy as a true pioneer in the realm of innovation.

Profile summary based on public USPTO records.